These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22108521)

  • 21. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
    Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
    J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
    Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
    Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
    Xiang J; Hang JB; Che JM; Li HC
    Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
    Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H
    Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
    Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
    Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The FBXW7 beta-form is suppressed in human glioma cells.
    Gu Z; Inomata K; Ishizawa K; Horii A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells.
    Bi Y; Yang Y; Zhang Y; Cheng C; Tang P; Xiao H; Yuan F; Wu W; Yang B
    Neoplasma; 2023 Dec; 70(6):733-746. PubMed ID: 38014700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
    Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
    Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
    Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
    Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYC is a critical target of FBXW7.
    Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
    Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant regulation of FBW7 in cancer.
    Wang L; Ye X; Liu Y; Wei W; Wang Z
    Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
    He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
    Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
    Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
    Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.
    Gombodorj N; Yokobori T; Tanaka N; Suzuki S; Kuriyama K; Kumakura Y; Yoshida T; Sakai M; Sohda M; Baatar S; Miyazaki T; Nishiyama M; Shirabe K; Kuwano H
    J Surg Oncol; 2018 Jul; 118(1):101-108. PubMed ID: 30098297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
    Cao J; Ge MH; Ling ZQ
    Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.